Ferrous cation

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Ferrous cation
Accession Number
DB14510
Description
Not Available
Type
Small Molecule
Groups
Experimental
Structure
Thumb
Weight
Average: 55.845
Monoisotopic: 55.934942133
Chemical Formula
Fe
Synonyms
  • Fe2+
  • Ferrous ion
  • Iron, ion (Fe2+)
  • Iron(2+)
  • Iron(2+) ion
  • Iron(II) ion

Pharmacology

Indication
Not Available
Associated Conditions
Contraindications & Blackbox Warnings
Learn about our commercial Contraindications & Blackbox Warnings data.
Learn More
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Learn about our commercial Adverse Effects data.
Learn More
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Purchasing individual compounds or compound libraries for your research?
Learn More

Categories

Drug Categories
Not Available
Classification
Not classified

Chemical Identifiers

UNII
GW89581OWR
CAS number
15438-31-0
InChI Key
CWYNVVGOOAEACU-UHFFFAOYSA-N
InChI
InChI=1S/Fe/q+2
IUPAC Name
lambda2-iron(2+) ion
SMILES
[Fe++]

References

General References
Not Available
Human Metabolome Database
HMDB0000692
KEGG Compound
C14818
ChemSpider
25394
RxNav
1541238
ChEBI
29033
PDBe Ligand
FE2
PDB Entries
1afr / 1aig / 1aij / 1biq / 1cc1 / 1cjx / 1dqk / 1drt / 1dry / 1ds1
show 833 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Tablet, coatedOral35 MG
Tablet, film coatedOral50 MG
Tablet65 MG
Tablet, film coatedOral100 MG
CapsuleOral100 mg
Capsule, delayed releaseOral50 MG
Tablet, film coatedOral
CapsuleOral
Capsule, extended releaseOral55 MG
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-0.77ChemAxon
pKa (Strongest Acidic)4.58ChemAxon
Physiological Charge2ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity0 m3·mol-1ChemAxon
Polarizability1.78 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Drug created on July 11, 2018 16:43 / Updated on June 12, 2020 10:53

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates